BXOS110 Injection in the Treatment of Acute Ischaemic Stroke

Clinical trial NCT06322394 · UNKNOWN

Trial details

NCT number: NCT06322394
Sponsor: Biocells (Beijing) Biotech Co.,Ltd
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2024-02-07
Primary completion: 2025-03-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.